← Latest news 
Fake drugs and Jan Aushadhi pressure pharma profits and shake market confidence
Economy
Published on 24 April 2026
A crowded market may not be a doom
India’s pharma market, valued around INR 2.17 lakh crore, faces mounting profit pressure as fake drugs erode trust and government Jan Aushadhi initiatives intensify competition. Industry voices point to early signs of fatigue, but many insist the sector isn’t collapsing and a rebound could still be on the horizon if enforcement and demand dynamics improve.
- Fake drugs are worsening losses and consumer confidence in pharma
- Jan Aushadhi is adding competitive pressure to branded players
- Experts see fatigue signals but not an outright doom scenario
- Potential rebound depends on market and enforcement conditions
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times